Solfarcos

100% Portuguese drug for rheumatoid arthritis to be tested on patients

Solfarcos' commitment to Sustainability and Innovation is news

Solfarcos is distinguished by Scoring as one of the best SMEs in Portugal

First liposomal drug for rheumatoid arthritis passes phase I in Portuguese clinical trial

Unilever's acquisition of K18 highlights Solfarcos's biotech haircare impact